GUIDA alle aziende

Abridge and AI Clinical Documentation

Abridge is a health AI company whose ambient documentation software listens to a consented doctor-patient visit and drafts a clinical note for the clinician to review and sign.

Ascolta questa guidaNarrato dall'IA · ~7 min

In questa pagina8 minuti di lettura
  1. Panoramica
  2. Punti chiave
  3. Immersione profonda
  4. Auditing one AI-drafted note against its source
  5. Implementazione nel mondo reale
  6. The Future of Abridge and AI Clinical Documentation
  7. Metterlo in pratica
  8. Fonti e approfondimenti
  9. Continua a esplorare
  10. Domande frequenti

Panoramica

It matters because documentation is a major source of clinician workload, and a 2025 JAMA Network Open study of its tool found burnout fell from 51.9% to 38.8% after 30 days.

Punti chiave

  1. Abridge records consented clinical visits and drafts a structured note that the clinician must review, edit and sign before it enters the record.
  2. Kaiser Permanente rolled Abridge out to 40 hospitals and more than 600 medical offices in August 2024 after testing and review.
  3. A 2025 JAMA Network Open study of 263 clinicians found burnout fell from 51.9% to 38.8% after 30 days of using Abridge.
  4. That study had no control group and relied on self-reported surveys, so it shows association rather than proven cause.
  5. Abridge says each part of a draft note can be checked against the original transcript and audio, which helps clinicians catch errors.

Immersione profonda

Abridge is a company that builds ambient clinical documentation, a category of software sometimes called an AI scribe. During a medical visit, with the patient's permission, the software records the conversation between clinician and patient. Afterward, it turns that recording into a draft of the clinical note, the formal record of symptoms, findings, assessment and plan that clinicians must write for every encounter. The clinician reviews, edits and signs the note, which is then filed in the electronic health record (EHR). The aim is to let clinicians look at the patient instead of a keyboard and to reduce the hours spent finishing notes after the clinic closes. Abridge's CEO and cofounder, Shiv Rao, is a practicing cardiologist, according to Fortune.

The process works in stages. First, the clinician starts a recording on a phone or in the EHR once the patient has agreed. Second, automatic speech recognition, which Abridge says is tuned for medical conversations, cross-talk and background noise, converts the audio into a transcript. Third, summarization pipelines that combine large language models with Abridge's own datasets and methods turn the transcript into a structured note organized into standard sections. Fourth, Abridge says it ties each span of the summary to supporting evidence in the conversation, so a clinician can check any sentence against the transcript and audio. Finally, the clinician edits and signs, and the note, along with other outputs such as patient summaries and billing-relevant detail, is placed in the chart.

Abridge's growth tracks the rapid adoption of this category. In August 2023 it became the first company in Epic's new Pals program, the developer program that replaced Epic's App Market, which allowed its tool to work inside Epic workflows. On August 14, 2024, Kaiser Permanente announced it was making Abridge available to clinicians at its 40 hospitals and more than 600 medical offices, after testing and quality review. Fortune reported in July 2025 that Abridge raised a 300 million dollar Series E led by Andreessen Horowitz with Khosla Ventures participating, at a 5.3 billion dollar valuation, up from 2.75 billion at its Series D, and that it was used in more than 150 enterprise health systems. Abridge's own website now says it is used by more than 300 health systems and powers more than 100 million conversations a year.

The strongest published evidence on outcomes is a quality improvement study in JAMA Network Open, published October 2, 2025, led by Kristine D. Olson of Yale School of Medicine. It surveyed ambulatory physicians and advanced practice clinicians at six US health systems before and 30 days after they began using the same version of the Abridge scribe, from February to October 2024. Among 263 clinicians analyzed, burnout fell from 51.9% to 38.8%. Clinicians also reported lower note-related cognitive load, better focused attention on patients, and 0.90 fewer hours per week of after-hours documentation. The intervention was funded by the participating institutions, and Abridge provided pooled survey data but had no role in design or analysis.

Those results come with real limits that the authors spell out. There was no control group, so changes over time or enthusiasm for a new tool could explain some of the improvement. Participants volunteered and responses were not anonymous, which may favor early adopters and positive answers. Outcomes were self-reported rather than measured from EHR activity logs, one site was excluded from the burnout analysis, and several authors disclosed ties to Abridge, including a current senior director. Customer-reported figures on Abridge's website, such as an 86% reduction in documentation effort at one health system, are company marketing claims rather than independent studies.

Compared with alternatives, ambient AI sits between older approaches. Clinicians can type notes themselves, which is accurate but time-consuming. Dictation software transcribes what the clinician says word for word but still requires them to compose the note. Human medical scribes, in the room or remote, can produce good notes but are expensive and hard to staff. Ambient AI tries to provide a scribe's output at software cost. Abridge's main differentiators, by its own account, are tight EHR integration and its traceability from note text back to the source conversation.

The risks are those of any generative AI applied to medical records. A language model can omit something important, attribute a statement to the wrong speaker, or confabulate, meaning produce plausible text that was never said; Abridge itself has published work on confabulation elimination, which acknowledges the problem. Because a signed note becomes a legal and clinical record, the clinician remains responsible for its accuracy, and review takes real attention. Recording patient conversations raises privacy and consent issues, which is why Kaiser Permanente requires patient agreement and Abridge states that it encrypts data and complies with state and federal privacy laws. Accuracy can also vary with accents, languages, noisy rooms and specialties.

In practice, adopting Abridge is an enterprise decision rather than an individual purchase. Health systems contract with the company, connect it to their EHR, set consent workflows, train clinicians, and monitor quality, often starting with pilots, as Kaiser Permanente did with testing before its 2024 rollout. Abridge also sells revenue-cycle features that aim to make documentation billing-ready, which links the product to coding and reimbursement and calls for compliance oversight. For patients, the visible change is usually a consent request at the start of a visit and, in some cases, a plain-language visit summary afterward.

04Esempio lavorato

Auditing one AI-drafted note against its source

  1. Pick a signed-off visit where an ambient scribe drafted the note and the transcript is available.

  2. List every medication, dose and allergy in the note.

  3. For each item, find the supporting moment in the transcript and confirm who said it and whether it was started, stopped or continued.

  4. List any clinically important facts from the transcript that are missing from the note.

  5. Mark any sentence in the note with no support in the transcript as a possible confabulation.

  6. Count supported items, omissions and unsupported sentences, and record how much editing the clinician did.

Cosa mostra

A simple accuracy profile for that note: how many statements were grounded, missed or unsupported. Repeating this on a sample of visits across specialties and languages gives a health system its own quality evidence instead of relying only on vendor or survey data.

Implementazione nel mondo reale

Kaiser Permanente made Abridge available to clinicians at 40 hospitals and more than 600 medical offices in eight states and Washington, D.C., in August 2024, requiring patient consent and clinician review of every note.

Working inside Epic: in August 2023 Abridge became the first company in Epic's Pals program for third-party developers, letting its notes flow into Epic clinical workflows instead of a separate app.

Checking a draft note: Abridge says clinicians can validate each part of a generated note against the underlying conversation transcript and audio recording before signing.

Nursing documentation: Abridge offers a nursing product that turns nurse-patient conversations into draft documentation, alongside its physician and revenue-cycle products.

Multilingual visits: Abridge states its speech recognition covers more than 14 languages, and customer AltaMed reports use across 28 languages at more than 60 centers.

The Future of Abridge and AI Clinical Documentation

The direction of the field is visible in Abridge's own product changes: from drafting physician notes toward nursing documentation, billing-ready coding detail, pre-visit summaries and in-visit prompts such as its Care Signals feature, which aims to ensure relevant conditions are addressed during the visit. Each step moves the software closer to clinical decision-making and reimbursement, raising the stakes of errors and the need for oversight. The main open question is evidence. The October 2025 JAMA Network Open study reported large drops in self-reported burnout after 30 days but had no control group, a limitation its authors state directly. Controlled trials that measure note accuracy, patient outcomes, billing effects and long-term clinician well-being are needed to judge whether early gains hold. Regulation and payer policy for AI-generated documentation are still developing. How Abridge's integration and traceability features compare with other ambient documentation products over time is also not settled.

Metterlo in pratica

Perché è importante

  • Strategia del fornitore. Le roadmap dei fornitori influenzano le funzionalità che il tuo team può sviluppare successivamente.
  • Costo e budget. I termini commerciali e le opzioni di implementazione influiscono sui costi e sui rischi a lungo termine.
  • Rischio e sicurezza. Gli incentivi aziendali modellano le impostazioni predefinite dei prodotti, la postura di sicurezza e l’apertura.

Attenzione

  • Gli annunci di lancio potrebbero superare la stabilità nei flussi di lavoro di produzione reali.
  • I prezzi delle API o i cambiamenti politici possono infrangere le ipotesi da un giorno all’altro.
  • La dipendenza da un unico fornitore aumenta i costi di lock-in e di migrazione.

Prossimi passi

  1. Valuta i fornitori utilizzando le tue attività e i tuoi set di dati.
  2. Esamina la privacy, la sicurezza e i termini legali prima dell'integrazione.
  3. Mantenere un piano di riserva tra modelli o fornitori.
  4. Monitora le note di rilascio in modo che le modifiche alla roadmap non sorprendano i team.

Fonti e approfondimenti

  1. JAMA Network Open (via PubMed Central)Use of Ambient AI Scribes to Reduce Administrative Burden and Professional Burnout
  2. Kaiser PermanenteKaiser Permanente improves member experience with AI-enabled clinical technology
  3. Healthcare DiveEpic, AI startup Abridge partner in third-party developer program
  4. FortuneAbridge CEO Shiv Rao on raising $300 million, a prospective IPO, and the future of healthcare
  5. AbridgeAbridge
  6. AbridgeAI at Abridge

Continua a esplorare

Newsletter gratuita

Ricevi il briefing quotidiano sull'IA

Tre storie verificate sull'IA ogni mattina nei giorni feriali, scritte in un inglese semplice. Gratuito per sempre, senza pubblicità.

Un'email ogni giorno feriale. Disiscriviti con un clic. Non vendiamo né condividiamo mai il tuo indirizzo.

Mettiti alla prova

Take the Abridge and AI Clinical Documentation quiz

Feedback immediato su ogni risposta e un certificato condivisibile con un ID verificabile una volta superato un corso.

Inizia il quiz

Sostieni l'istruzione gratuita sull'IA. AI Understanding è un'organizzazione non profit 501(c)(3) — nessun annuncio, nessun paywall, mai. Fai una donazione

Domande frequenti

What is Abridge and AI Clinical Documentation?

Abridge is a health AI company whose ambient documentation software listens to a consented doctor-patient visit and drafts a clinical note for the clinician to review and sign. It matters because documentation is a major source of clinician workload, and a 2025 JAMA Network Open study of its tool found burnout fell from 51.9% to 38.8% after 30 days.

Quale problema è principalmente progettato per risolvere Abridge?

Abridge affronta il pesante carico di lavoro di scrittura di appunti che contribuisce al burnout dei medici automatizzando la documentazione clinica.

Cosa significa "ambiente" nel contesto di Abridge?

L'intelligenza artificiale ambientale cattura la conversazione naturale medico-paziente in modo discreto, anziché richiedere una dettatura strutturata.

Quale caratteristica distintiva consente ai medici di fidarsi dei risultati di Abridge?

Riunisce il testo generato nell'audio sorgente, consentendo ai medici di verificare qualsiasi affermazione: una caratteristica chiave di fiducia e responsabilità.

Chi ha fondato Abridge e con quale background?

Abridge è stata fondata nel 2018 da Shiv Rao, un cardiologo praticante.

Come si inserisce Abridge nei flussi di lavoro ospedalieri esistenti?

La profonda integrazione EHR fa sì che le note fluiscano automaticamente nella cartella clinica del paziente in sistemi come Epic.